Obstetric antiphospholipid syndrome

Autoimmunity Reviews

Volumn 11, Issue 4, 2012, Pages 288-295

  Galarza Maldonado, Claudio ^a   Kourilovitch, Maria R ^a   Pérez Fernández, Oscar M ^b   Gaybor, Mariana ^a,c   Cordero, Christian ^a   Cabrera, Sonia ^a   Soroka, Nikolai F ^d  

^a Mont Sinai Hospital   (Ecuador)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c Unit of Obstetrics and Gynecology   (Ecuador)

^d Municipal Clinical Hospital N 9   (Belarus)

Author keywords

Antiphospholipid antibodies; Obstetric antiphospholipid syndrome; Recurrent pregnancy miscarriage

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBODY; ANTITHROMBIN; AUTOANTIBODY; BETA 2 GLYCOPROTEIN 1 ANTIBODY; BETAMETHASONE; CARDIOLIPIN ANTIBODY; DALTEPARIN; DEXAMETHASONE; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; NADROPARIN; PREDNISOLONE; PREDNISONE; UNCLASSIFIED DRUG; WARFARIN;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; HUMAN; HYPERCOAGULABILITY; LABORATORY TEST; LOW DRUG DOSE; MORBIDITY; NONHUMAN; PRECONCEPTION INJURY; PREGNANCY; PUERPERIUM; REVIEW; SPONTANEOUS ABORTION; STANDARDIZATION; TERATOGENICITY; THROMBOSIS; VASCULAR DISEASE;

ABORTION, HABITUAL; ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; BLOOD COAGULATION; DISEASE MODELS, ANIMAL; FEMALE; HEPARIN; HUMANS; IMMUNOTHERAPY; INDIVIDUALIZED MEDICINE; MICE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84857037673     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.10.006     Document Type: Review

References (55)

1. Vinatier D., Dufour P., Cosson M., Houpeau J.L. Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol 2001, 96:37-50.
2. Drakeley A.J., Quenby S., Farquharson R. Mid-trimester loss - appraisal of a screening protocol. Hum Reprod 1998, 13:1975-1980.
3. Cervera R., Piette J.-C., Font J., Khamashta M.A., Shoenfeld Y., Camps M.T. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002, 46:1019-1027.
4. Cervera R., Khamashta M., Shoenfeld Y., Camps M., Jacobsen S., Kiss E., et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 2009, 68:1428-1432.
5. Tincani A., Bazzani C., Zingarelli S., Lojacono A. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment. Semin Thromb Hemost 2008, 34:267-273.
6. Asherson R.A., Galarza-Maldonado C., Sanin-Blair J. The HELLP syndrome, antiphospholipid antibodies, and syndromes. Clin Rheumatol 2008, 27:1-4.
7. Gómez-Puerta J.A., Sanin-Blair J., Galarza-Maldonado C. Pregnancy and catastrophic antiphospholipid syndrome. Clin Rev Allergy Immunol 2009, 36:85-90.
8. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999, 42:1309-1311.
9. Miyakis S., Lockshin M., Atsumi T., Branch D., Brey R., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
10. Branch W. Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010. Lupus 2011, 20:158-164.
11. Blank M., Cohen J., Toder V., Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 1991, 88:3069-3073.
12. Bakimer R., Fishman P., Blank M., Sredni B., Djaldetti M., Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992, 89:1558-1563.
13. Ornoy A., Yacobi S., Tartakover Matalon S., Blank M., Blumenfeld M. The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture. Lupus 2003, 12:573-578.
14. Rand J.H. The antiphospholipid syndrome. Annu Rev Med 2003, 54:409-424.
15. Shoenfeld Y., Sherer Y., Fishman P. Interleukin-3 and pregnancy loss in antiphospholipid syndrome. Scand J Rheumatol Suppl 1998, 107:19-22.
16. Gharavi A.E., Sammaritano L.R., Wen J., Elkon K.B. Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H). J Clin Invest 1992, 90:1105-1109.
17. Garcia C.O., Kanbour-Shakir A., Tang H., Molina J.F., Espinoza L.R., Gharavi A.E. Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with beta 2 GPI. Am J Reprod Immunol 1997, 37:118-124.
18. Gharavi A.E., Pierangeli S.S., Colden-Stanfield M., Liu X.W., Espinola R.G., Harris E.N. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro. J Immunol 1999, 163:2922-2927.
19. Carp H.J. Antiphospholipid syndrome in pregnancy. Curr Opin Obstet Gynecol 2004, 16:129-135.
20. Magid M.S., Kaplan C., Sammaritano L.R., Peterson M., Druzin M.L., Lockshin M.D. Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol 1998, 179:226-234.
21. Levy R.A., Avvad E., Oliveira J., Porto L.C. Placental pathology in antiphospholipid syndrome. Lupus 1998, 7(Suppl. 2):S81-S85.
22. Carreras L.O., Defreyn G., Machin S.J., Vermylen J., Deman R., Spitz B., et al. Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981, 1:244-246.
23. Schorer A.E., Duane P.G., Woods V.L., Niewoehner D.E. Some antiphospholipid antibodies inhibit phospholipase A2 activity. J Lab Clin Med 1992, 120:67-77.
24. Chamley L.W., McKay E.J., Pattison N.S. Inhibition of heparin/antithrombin III cofactor activity by anticardiolipin antibodies: a mechanism for thrombosis. Thromb Res 1993, 71:103-111.
25. Cariou R., Tobelem G., Soria C., Caen J. Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant. N Engl J Med 1986, 314:1193-1194.
26. Rand J.H., Wu X.X., Guller S., Gil J., Guha A., Scher J., et al. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 1994, 171:1566-1572.
27. Meroni P.L., di Simone N., Testoni C., D'Asta M., Acaia B., Caruso A. Antiphospholipid antibodies as cause of pregnancy loss. Lupus 2004, 13:649-652.
28. Sthoeger Z.M., Mozes E., Tartakovsky B. Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci U S A 1993, 90:6464-6467.
29. Di Simone N., Meroni P.L., De Papa N., Raschi E., Caliandro D., De Carolis C.S., et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000, 43:140-150.
30. Blank M., Krause I., Fridkin M., Keller N., Kopolovic J., Goldberg I., et al. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002, 109:797-804.
31. Manco-Johnson M.J., Nuss R., Key N., Moertel C., Jacobson L., Meech S., et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996, 128:319-323.
32. García-Carrasco M., Galarza-Maldonado C., Mendoza-Pinto C., Escarcega R.O., Cervera R. Infections and the antiphospholipid syndrome. Clin Rev Allergy Immunol 2009, 36:104-108.
33. Namjou B. Antiphospholipid syndrome: genetic review. Curr Rheumatol Rep 2003, 5:391-394.
34. Shamonki J.M., Salmon J.E., Hyjek E., Baergen R.N. Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol 2007, 196(167):e1-e5.
35. Girardi G., Redecha P., Salmon J.E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004, 10:1222-1226.
36. Girardi G., Berman J., Redecha P., Spruce L., Thurman J.M., Kraus D., et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003, 112:1644-1654.
37. Shoenfeld Y., Krause I., Kvapil F., Sulkes J., Lev S., Von Landenberg P., et al. Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome. J Clin Immunol 2003, 23:377-383.
38. Gharavi A.E., Pierangeli S.S., Levy R.A., Harris E.N. Mechanisms of pregnancy loss in antiphospholipid syndrome. Clin Obstet Gynecol 2001, 44:11-19.
39. Backos M., Rai R., Regan L. Antiphospholipid antibodies and infertility. Hum Fertil (Camb) 2002, 5:30-34.
40. Orts J.A., Zúñiga A., Orera M. Antiphospholipid syndrome updating. Med Clin (Barc) 2003, 121:459-471.
41. Levy R.A., de Meis E., Pierangeli S. An adapted ELISA method for differentiating pathogenic from nonpathogenic aPL by a beta 2 glycoprotein I dependency anticardiolipin assay. Thromb Res 2004, 114:573-577.
42. Cervera R., García-Carrasco M., Rojas-Rodríguez J., Asherson R.A. Anticuerpos antifosfolípidos. Trombosis en la práctica clínica 2003, 113-121. Intersistemas, Mexico. C. Galarza-Maldonado, C. Pineda Villaseñor, R. Cervera Segura (Eds.).
43. Piereangeli S.S., Gharavi A., Harris E.N. Pruebas de anticuerpos antifosfolìpidos: problemas y soluciones. Anticuerpos antifosfolìpidos y problemas de la reproducción 2001, 43-51. Clínicas obstétricas y ginecológicas, México. W. Branco (Ed.).
44. Balasch J., Carmona F., Creus M. Management of reproductive failure in the antiphospholipid syndrome. The antiphospholipid syndrome II-Autoimmune Thrombosis 2002, 375-394. Elsevier, Amsterdam. R.A. Asherson, R. Cervera, J.C. Piette, Y. Shoenfeld (Eds.).
45. Rai R., Cohen H., Dave M., Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997, 314:253-257.
46. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996, 174:1584-1589.
47. Farquharson R.G., Quenby S., Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002, 100:408-413.
48. Ginsberg J.S., Greer I., Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001, 119:122S-131S.
49. Lockshin M.D., Sammaritano L.R. Corticosteroids during pregnancy. Scand J Rheumatol Suppl 1998, 107:136-138.
50. Derksen R.H.W.M., Khamashta M.A., Branch D.W. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 2004, 50:1028-1039.
51. Galarza-Maldonado C., Cervera R., Urgilez H. Síndrome antifosfolipídico: veintiún años después. Rev Col Reumatol 2004, 11:48-54.
52. Branch D.W., Khamashta M.A. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol 2003, 101:1333-1344.
53. Lockshin M.D., Druzin M.L., Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989, 160:439-443.
54. Tincani A., Branch W., Levy R.A., Piette J.C., Carp H., Rai R.S., et al. Treatment of pregnant patients with antiphospholipid syndrome. Lupus 2003, 12:524-529.
55. Berman J., Girardi G., Salmon J.E. TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss. J Immunol 2005, 174:485-490.